Yüklüyor......
Modulation of host metabolism as a target of new antivirals()
The therapy for chronic hepatitis C (CH–C) started with interferon (IFN) monotherapy in the early 1990s and this therapy was considered effective in about 10% of cases. The present standard therapy of pegylated IFN with ribavirin achieves a sustained virologic response in about 50% of patients. Howe...
Kaydedildi:
| Yayımlandı: | Adv Drug Deliv Rev |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier B.V.
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103349/ https://ncbi.nlm.nih.gov/pubmed/17897752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2007.03.021 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|